Jump to content

Chula to Test its COVID-19 Vaccine in Volunteers


webfact

Recommended Posts

Chula to Test its COVID-19 Vaccine in Volunteers

 

chula.jpg

 

BANGKOK, Feb 18 (TNA) - The Faculty of Medicine of Chualongkorn University will test its COVID-19 vaccine in volunteers in either late April or early May after successful trial in monkeys last year.

 

Prof Dr Suttipong Wacharasindhu, director of Chulalongkorn Hospital, said the second jab of the mRNA-typed ChulaCov19 vaccine proved to make monkeys develop high immunity and have good health and therefore the faculty had confidence to try it in volunteers.

 

Chulalongkorn Hospital and the Chula Vaccine Research Center prepared places and personnel for trial in human. They prioritized safety for public confidence in the trial progress, he said.

 

Full story: https://tna.mcot.net/english-news/line-today-english-news-639590

 

 

tnalogo.jpg
  • Haha 1
Link to comment
Share on other sites

Thai-developed vaccine set to proceed to human trials

 

download (1).jpg

 

BANGKOK (Reuters) - Thailand's second domestically developed vaccine will soon undergo human trials, officials said on Thursday, adding that the plan was to produce up to five million doses by the end of the year.

 

The vaccine, developed by Thailand's Chulalongkorn University, had success in trials in mice and monkeys and is due to be tested on humans in late April or early May, Kiat Ruxrungtham of the Chula Vaccine Research Center said.

 

"By year-end we should have a production capacity of one to five million doses annually," Kiat told a news conference, adding this could later rise to about 20 million doses per year.

 

The announcement comes amid criticism that Thailand's vaccine strategy has been slow and too reliant on AstraZeneca shots being produced by local manufacturer Siam Bioscience, owned by the country's king.

 

The Thai-developed "ChulaCov19" vaccines are initially being produced in California, but will be produced locally in later stages by Thai company Bionet Asia, he said.

 

Kiat said the university was already developing vaccines to guard against the highly contagious British and South African variants of COVID-19.

 

Public health minister Anutin Charnvirakul welcomed progress towards greater vaccine security in Thailand, which has recorded 25,111 infections and 82 deaths since the pandemic started.

 

"We are not betting on one horse but are owners of the stable in Thailand," he told reporters.

 

Another Thai-developed vaccine involving Mahidol University is also scheduled for human trials, but also won't be available, if approved, until later than locally made AstraZeneca doses.

 

The government has ordered 26 million doses of the locally made AstraZeneca shots for use in vaccinations from June and plans to administer 10 million doses per month from that point.

 

However, Anutin appeared to back away from an earlier statement that Thailand would import 50,000 "early doses" from AstraZeneca sometime this month.

 

"We asked them if they could send doses earlier if they had them, but it is not an agreement," he told reporters.

 

Thailand on Thursday also recorded the first death of a doctor who had contracted the virus from patients, Anutin said. His death will be included in Friday's tally.

 

reuters_logo.jpg

-- © Copyright Reuters 2021-02-18
 
  • Haha 1
Link to comment
Share on other sites

Pure hubris when they're supposed to be a regional hub for manufacturing the AZ vaccine. Imperial College in London stopped development of its vaccine after the approval of the Pfizer and AZ versions, and is now focusing on developing boosters against new variants instead. The Thai government should find a better focus for its efforts. 

Link to comment
Share on other sites

Day late and dollar short. By year end able to produce 5 million doses.... wow. Amazing Thailand. So 15+ years to dose the population. Saying they could ramp up later to 20 mil a year is still pitiful at best. Guess they had to come up with something to justify research costs...

  • Like 1
Link to comment
Share on other sites

The truth of the matter is that it just shows what a mess the world we live in is.

Money before peoples health.

The supposed "safe & effective vaccine" recipe or whatever it is called  if they do indeed exist should have been shared around the world to every country in the world to begin production

as soon as possible.

This was in the actual MOU agreed by BIG Pharma but instead  they used it for toilet paper 

when sh////t  came to shove.

Disgracful capitalism at it's worst

  • Like 1
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.




×
×
  • Create New...